Mint Tower Capital Management B.V. Pfizer Inc Put Options Transaction History

Mint Tower Capital Management B.V.

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 04, 2022	SELL	$41.32 - $61.25 $1.61 Million - $2.39 Million	-39,000 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$39.25 - $50.42 $1.64 Million - $2.1 Million	-41,700 Reduced 51.67%	39,000 $1.68 Million
Q2 2021 Aug 02, 2021	BUY	$35.91 - $40.68 $1.49 Million - $1.68 Million	41,400 Added 105.34%	80,700 $3.16 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $1.32 Million - $1.48 Million	39,300 New	39,300 $1.41 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $2.1 Million - $2.46 Million	-66,000 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$30.12 - $36.54 $1.42 Million - $1.72 Million	47,000 Added 247.37%	66,000 $2.16 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $35,139 - $50,206	-1,300 Reduced 6.4%	19,000 $614,000
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $761,250 - $836,360	20,300 New	20,300 $862,000
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $9.03 Million - $11 Million	-262,000 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $8.64 Million - $9.21 Million	262,000 New	262,000 $9.51 Million

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

Stay updated on Mint Tower Capital Management B.V. with notifications on news.